Genesys International Corporation Limited
NSE:GENESYS.NS
792.85 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,982.429 | 1,811.285 | 1,165.103 | 795.588 | 1,054.468 | 1,147.309 | 1,137.674 | 766.81 | 469.557 | 602.655 | 751.179 | 1,137.494 | 959.872 | 950.652 | 742.858 | 835.419 | 472.845 | 192.308 |
Cost of Revenue
| 993.068 | 1,033.907 | 806.68 | 626.448 | 799.115 | 765.203 | 597.63 | 370.879 | 293.786 | 306.454 | 446.972 | 100.927 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 989.361 | 777.378 | 358.423 | 169.14 | 255.353 | 382.107 | 540.043 | 395.931 | 175.771 | 296.201 | 304.207 | 1,036.567 | 959.872 | 950.652 | 742.858 | 835.419 | 472.845 | 192.308 |
Gross Profit Ratio
| 0.499 | 0.429 | 0.308 | 0.213 | 0.242 | 0.333 | 0.475 | 0.516 | 0.374 | 0.491 | 0.405 | 0.911 | 1 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 72.477 | 81.61 | 36.961 | 33.508 | 26.703 | 21.153 | 39.109 | 0 | 0 | 0 | 50.8 | 83.604 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 111.497 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.861 | 67.883 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 183.974 | 81.61 | 36.961 | 33.508 | 26.703 | 21.153 | 39.109 | 119.405 | 96.808 | 20.836 | 109.661 | 151.487 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Expenses
| 50.264 | 65.015 | 7.13 | 4.612 | 7.574 | 6.582 | 27.611 | 182.812 | 163.457 | 251.37 | 226.189 | 828.349 | 2.962 | 2.467 | 2.955 | 6.335 | 311.909 | 2.984 |
Operating Expenses
| 628.776 | 565.776 | 265.991 | 369.161 | 335.171 | 376.875 | 300.26 | 182.812 | 163.457 | 251.37 | 226.189 | 828.349 | 636.543 | 458.708 | 351.542 | 506.536 | 311.909 | 167.554 |
Operating Income
| 410.849 | 211.626 | 83.679 | -188.589 | -77.867 | -0.037 | 239.783 | 211.53 | 45.921 | 51.418 | 85.954 | 237.157 | 323.329 | 491.944 | 391.315 | 328.883 | 160.936 | 24.754 |
Operating Income Ratio
| 0.207 | 0.117 | 0.072 | -0.237 | -0.074 | -0 | 0.211 | 0.276 | 0.098 | 0.085 | 0.114 | 0.208 | 0.337 | 0.517 | 0.527 | 0.394 | 0.34 | 0.129 |
Total Other Income Expenses Net
| -39.094 | 38.33 | -442.364 | -355.846 | 11.609 | 3.742 | -4.649 | -1.59 | 33.607 | 6.587 | 7.936 | 28.939 | -139.33 | -42.085 | -15.305 | -21.335 | -4.671 | -2.149 |
Income Before Tax
| 371.755 | 249.956 | -358.685 | -544.435 | -66.258 | 3.705 | 235.134 | 211.53 | 45.921 | 51.418 | 85.954 | 237.157 | 183.999 | 449.859 | 376.01 | 307.548 | 156.265 | 22.604 |
Income Before Tax Ratio
| 0.188 | 0.138 | -0.308 | -0.684 | -0.063 | 0.003 | 0.207 | 0.276 | 0.098 | 0.085 | 0.114 | 0.208 | 0.192 | 0.473 | 0.506 | 0.368 | 0.33 | 0.118 |
Income Tax Expense
| 155.632 | 100.638 | 38.169 | -26.553 | -15.403 | 41.026 | 64.992 | 24.448 | 2.865 | 5.659 | 17.597 | 30.944 | 19.54 | -6.399 | 49.097 | -2.288 | 6.399 | 1.249 |
Net Income
| 220.729 | 190.778 | 134.115 | -517.882 | -50.855 | -37.321 | 170.057 | 159.354 | 22.19 | 45.759 | 68.358 | 206.213 | 164.459 | 460.313 | 326.913 | 309.836 | 149.866 | 21.355 |
Net Income Ratio
| 0.111 | 0.105 | 0.115 | -0.651 | -0.048 | -0.033 | 0.149 | 0.208 | 0.047 | 0.076 | 0.091 | 0.181 | 0.171 | 0.484 | 0.44 | 0.371 | 0.317 | 0.111 |
EPS
| 5.78 | 5.43 | 4.29 | -16.61 | -1.63 | -1.2 | 5.54 | 5.14 | 0.73 | 1.45 | 2.29 | 6.91 | 5.51 | 15.82 | 10.96 | 11 | 6.48 | 0.84 |
EPS Diluted
| 5.74 | 5.27 | 4.01 | -16.61 | -1.62 | -1.18 | 5.3 | 5.02 | 0.72 | 1.45 | 2.29 | 6.91 | 5.51 | 15.82 | 10.96 | 11 | 5.4 | 0.67 |
EBITDA
| 855.651 | 651.915 | 307.179 | -1.731 | 168.779 | 220.383 | 418.647 | 295.437 | 130.916 | 150.847 | 172.514 | 328.288 | 438.464 | 558.043 | 417.224 | 351.232 | 183.022 | 41.733 |
EBITDA Ratio
| 0.432 | 0.36 | 0.264 | -0.002 | 0.16 | 0.192 | 0.368 | 0.385 | 0.279 | 0.25 | 0.23 | 0.289 | 0.457 | 0.587 | 0.562 | 0.42 | 0.387 | 0.217 |